EP1154783A4 - Relaxin-enthaltende medikamente und deren verwendung - Google Patents

Relaxin-enthaltende medikamente und deren verwendung

Info

Publication number
EP1154783A4
EP1154783A4 EP00938984A EP00938984A EP1154783A4 EP 1154783 A4 EP1154783 A4 EP 1154783A4 EP 00938984 A EP00938984 A EP 00938984A EP 00938984 A EP00938984 A EP 00938984A EP 1154783 A4 EP1154783 A4 EP 1154783A4
Authority
EP
European Patent Office
Prior art keywords
relaxin
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00938984A
Other languages
English (en)
French (fr)
Other versions
EP1154783A1 (de
Inventor
Raziel Lurie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/348,062 external-priority patent/US6075005A/en
Application filed by Individual filed Critical Individual
Publication of EP1154783A1 publication Critical patent/EP1154783A1/de
Publication of EP1154783A4 publication Critical patent/EP1154783A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00938984A 1999-07-06 2000-07-03 Relaxin-enthaltende medikamente und deren verwendung Withdrawn EP1154783A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/348,062 US6075005A (en) 1993-10-03 1999-07-06 Medicaments comprising relaxin and their use
US348062 1999-07-06
PCT/IB2000/000901 WO2001001997A1 (en) 1999-07-06 2000-07-03 Medicaments comprising relaxin and their use

Publications (2)

Publication Number Publication Date
EP1154783A1 EP1154783A1 (de) 2001-11-21
EP1154783A4 true EP1154783A4 (de) 2005-01-19

Family

ID=23366490

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00938984A Withdrawn EP1154783A4 (de) 1999-07-06 2000-07-03 Relaxin-enthaltende medikamente und deren verwendung

Country Status (4)

Country Link
EP (1) EP1154783A4 (de)
AU (1) AU771256B2 (de)
CA (1) CA2378598A1 (de)
WO (1) WO2001001997A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224780B1 (es) * 2002-02-21 2007-03-01 Adnan Ammura Taha Composicion regeneradora capilar.
US7320967B2 (en) 2002-04-23 2008-01-22 L'oreal Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
ES2576655B1 (es) * 2015-01-08 2017-04-20 Anastasio SOLANA MURILLO Tratamiento capilar compuesto de acetato de ciproterona
MX2018001546A (es) * 2018-02-06 2019-08-07 Centro Int De Cosmiatria S A P I De C V Formulacion y metodo para el tratamiento de la alopecia androgenica.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028525A2 (de) * 1979-10-31 1981-05-13 Orion-Yhtymä Oy Behandlungsmittel zur Verbesserung des Haarwuchses und Verhütung von Kopfschuppen
US4596812A (en) * 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
WO1995003319A1 (en) * 1993-07-23 1995-02-02 The Procter & Gamble Company Cyproterone acetate thioacetate
WO1995009644A1 (en) * 1993-10-03 1995-04-13 Knowhow Licensing & Knowhow Transfer B.V. Medicaments comprising relaxin and their use
WO1997011702A1 (en) * 1995-09-27 1997-04-03 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096246A (en) * 1960-05-24 1963-07-02 Warner Lambert Pharmaceutical Process for the extraction and purification of relaxin
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596812A (en) * 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
EP0028525A2 (de) * 1979-10-31 1981-05-13 Orion-Yhtymä Oy Behandlungsmittel zur Verbesserung des Haarwuchses und Verhütung von Kopfschuppen
WO1995003319A1 (en) * 1993-07-23 1995-02-02 The Procter & Gamble Company Cyproterone acetate thioacetate
WO1995009644A1 (en) * 1993-10-03 1995-04-13 Knowhow Licensing & Knowhow Transfer B.V. Medicaments comprising relaxin and their use
WO1997011702A1 (en) * 1995-09-27 1997-04-03 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0101997A1 *

Also Published As

Publication number Publication date
WO2001001997A1 (en) 2001-01-11
AU5419900A (en) 2001-01-22
EP1154783A1 (de) 2001-11-21
AU771256B2 (en) 2004-03-18
CA2378598A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
NZ514062A (en) Diaryl derivatives and their use as medicaments
ZA9811086B (en) Delivery devices and their use
HRP20010655B1 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
IL145715A0 (en) Formulation arrays and use thereof
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
HK1050673A1 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
EP1154783A4 (de) Relaxin-enthaltende medikamente und deren verwendung
HUP0201478A3 (en) Neuroprotective and retinoprotective ophthalmologic medicines
HUP0105351A3 (en) Effervescent laxatives and their use
HUP0200812A3 (en) Vitamin d analogues and their pharmaceutical use
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
EP1224939A4 (de) Interferon komplex und dessen medizinische verwendung
HUP0203678A3 (en) Nitro-sulfobenzamide-derivatives, preparation and use thereof
GB9929581D0 (en) Comjpositions and their use
GB9903919D0 (en) Aminophenols and their therapeutic use
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
GB9921248D0 (en) Medicament and assay
GB9926528D0 (en) Therapeutic use and formulation
EG21695A (en) Pin-screw-ajusting and safe
GB9923431D0 (en) Pharmaceutical compositions and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010910

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041206

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/506 B

Ipc: 7A 61P 43/00 B

Ipc: 7A 61K 31/44 B

Ipc: 7A 61K 38/00 A

17Q First examination report despatched

Effective date: 20081104

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080801